Montelukast reduces grey matter abnormalities and functional deficits in a mouse model of inflammation-induced encephalopathy of prematurity. (2022)

First Author: Yates AG
Attributed to:  MRC Centre for Neurodevelopmental Disorders funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1186/s12974-022-02625-5

PubMed Identifier: 36309753

Publication URI: http://europepmc.org/abstract/MED/36309753

Type: Journal Article/Review

Volume: 19

Parent Publication: Journal of neuroinflammation

Issue: 1

ISSN: 1742-2094